|
October 5, 2007 Neuromed President & CEO Dr. Christopher Gallen Named Finalist for Scrip Award's "Executive of the Year" Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, is pleased to announce its President & CEO, Dr. Christopher Gallen, has been named a finalist for a 2007 Scrip Award in the category of “Executive of the Year.” September 27, 2007 GARDASIL(R) (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine), Merck's vaccine for the prevention of cervical cancer, received the Prix Galien USA 2007 Award for Best Biotechnology product, Merck & Co., Inc. announced today. In addition, JANUVIA(TM) (sitagliptin), the Company's treatment of type 2 diabetes, received the 2007 Award for Best Pharmaceutical Agent. Both were presented at a ceremony in New York City on Sept. 25. September 12, 2007 2007 BC Innovation Council Award Winners: British Columbia's Innovation Forerunners Recognized for Outstanding Achievements Mr. Hector MacKay-Dunn, QC, Chair of BC Innovation Council, is pleased to announce five outstanding British Columbians as winners of the 2007 BC Innovation Council Awards. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |